Show/hide contentOpenClose All
Curricular information is subject to change
•A theoretical framework that allows a structured thinking about the pharma/biotech industry
•An understanding of the complexity of the business, market forces, scientific drivers and changing contexts
•Decision making processes under high risk, including such topics as risk aversion in drug regulation
•A reflection on the reputation of the pharma/ biotech industry
•To understand how the industry capitalises on the increasing complexity of the biological sciences and regulations
•To understand the impact of high drug prices and potential solutions such as the Health Impact Fund
•Insight into the future of the bio-economy
Student Effort Type | Hours |
---|---|
Lectures | 16 |
Specified Learning Activities | 30 |
Autonomous Student Learning | 70 |
Total | 116 |
Not applicable to this module.
Remediation Type | Remediation Timing |
---|---|
In-Module Resit | Prior to relevant Programme Exam Board |
• Feedback individually to students, post-assessment
Written feedback to be provided within 20 days of assignment deadline.
Name | Role |
---|---|
Professor Jan Rosier | Lecturer / Co-Lecturer |